The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients.

Bogdan KolarzMarek CieslaAnn K RosenthalMagdalena DryglewskaMaria Majdan

Published in: Therapeutic advances in musculoskeletal disease (2021)

Anti-CarP but not anti-PAD4 may be a useful biomarker in identifying ACPA/RF negative RA patients. This antibody may identify an additional RA population who may benefit from early implementation of aggressive therapy.

Keyphrases

rheumatoid arthritis
disease activity
rheumatoid arthritis patients
primary care
ejection fraction
healthcare
newly diagnosed
end stage renal disease
ankylosing spondylitis
systemic lupus erythematosus
interstitial lung disease
stem cells
prognostic factors
systemic sclerosis
replacement therapy